Yale School of Medicine
New Haven, CT, United States
Dr. Koumpouras is an expert in the diagnosis and management of systemic lupus erythematosus (SLE). He is also an authority on clinical trials for SLE. He is clinical director of the Yale Lupus Program since the Summer of 2015.
At Yale, Dr. Koumpouras focuses his academic and scholarship activity on clinical research and clinical trials. He has been part of multi-center clinical trials leading to new therapies for SLE in 2011 and 2020. He leads a dedicated team focused on comprehensive SLE care. he also founded and is co-Director of the Yale rheumatology-dermatology clinic. Dr. Koumpouras is currently developing the Yale Autoimmune Cellular Therapy program.
In addition to his clinical work, Dr. Koumpouras serves as Training Program Director and CME course director for Yale Rheumatology. He is a standing member on the COTW at the ACR and together with Rachel Wolfe is developing a mentor program for new rheumatology Program Directors.
Dr. Koumpouras leverages his skills as an academic clinician and trialist to further collaborative research in lupus, while fostering education for next generation of rheumatologists.
Aside from his career activities, Dr. Koumpouras enjoys ancient history, art, beach combing, poetry, chess and walking his dogs.
Case-based Primary Care Curriculum
Monday, November 13, 2023
11:15 AM – 11:30 AM PT
Disclosure(s): AstraZeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bristol-Myers Squibb(BMS): Grant/Research Support (Ongoing); Cabaletta Bio: Advisor or Review Panel Member (Ongoing); GlaxoSmithKlein(GSK): Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 1, 2022); LRA: Grant/Research Support (Ongoing); Novartis: Advisor or Review Panel Member (Terminated, September 1, 2022)
